Ethos Technologies (LIFE)
Nasdaq Market Open
Ethos Technologies Inc. is a life insurance technology company built around a digital, direct-to-consumer distribution model. The company’s platform is designed to make buying life insurance simpler by allowing customers to research coverage, compare policy options, submit applications, and complete much of the underwriting process online. Its Class A common stock gives public-market investors exposure to a business operating at the intersection of insurance distribution, consumer fintech, and data-driven underwriting.
Ethos works with insurance carriers rather than underwriting policies entirely on its own balance sheet. Its technology connects consumers with term and other life insurance products offered by carrier partners, while using data analytics, automated workflows, and online interfaces to reduce friction in the application and policy issuance process. The platform also supports independent agents, giving the company a hybrid model that combines digital customer acquisition with agent-assisted sales where needed.
Revenue is primarily generated from commissions paid by insurance carriers when policies are activated through the Ethos platform. The company also provides third-party administrator services connected to policies sold through its channels, adding another service-based revenue stream. This model ties Ethos’ growth to its ability to attract prospective policyholders, improve conversion rates, maintain carrier relationships, and support efficient policy servicing.
Ethos operates in the large US life insurance market, where many consumers remain underinsured and traditional application processes can be time-consuming. Its distinctive feature is the use of proprietary technology to modernize distribution and underwriting rather than relying solely on legacy broker or agent networks.
Last updated
- Market Cap
- —
- P/E
- —
- P/FCF
- —
- P/S
- —
- Enterprise Value
- —
- Sector
- Financials
- Industry
- Insurance Agents, Brokers, and Service
- Address
- 1606 HEADWAY CIRCLE, AUSTIN, TX, 78754
aTyr Pharma Announces Nasdaq Stock Ticker Symbol Change from “LIFE” to “ATYR”
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
aTyr Pharma to Present Poster Describing Efzofitimod’s Mechanism of Action at the American Thoracic Society 2024 International Conference
aTyr Pharma Announces Second Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis
aTyr Pharma Announces First Quarter 2024 Results and Provides Corporate Update
aTyr Pharma to Participate in April Investor Conferences
aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update
aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2023 Financial Results
aTyr Pharma Presents Poster Demonstrating Preclinical Effects of Efzofitimod in Rheumatoid Arthritis and Rheumatoid Arthritis-Associated ILD at the ACR Convergence 2023
aTyr Pharma Announces Third Quarter 2023 Results and Provides Corporate Update
aTyr Pharma Presents Efzofitimod Data Demonstrating Statistically Significant Improvements in Time to Relapse, FVC and Patient Reported Outcomes
5 Top Stocks to Play Earnings Beat Potential
Down -9.64% in 4 Weeks, Here's Why You Should You Buy the Dip in Atyr Pharma (LIFE)
aTyr Pharma to Present at the H.C. Wainwright 25th Annual Global Investment Conference
5 Top Stocks Likely to Top Earnings Estimates
Atyr Pharma (LIFE) Reports Q2 Loss, Lags Revenue Estimates
aTyr Pharma Announces Second Quarter 2023 Results and Provides Corporate Update
aTyr Pharma to Present on Lead Therapeutic Candidate Efzofitimod at the World Association for Sarcoidosis and Other Granulomatous Disorders (WASOG) Conference
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
aTyr Pharma to Present at the 2023 Jefferies Healthcare Conference
Income Statement
| Line Item | 2026 Q1 |
|---|---|
| Revenue | 193.1M |
| Gross profit | 189.87M |
| Operating income | -163.31M |
| EBITDA | -161.97M |
| Net income | -172.03M |
| Basic EPS | -3.57 |
| Diluted EPS | -3.57 |
Balance Sheet
| Line Item | 2026 Q1 |
|---|---|
| Total assets | 619.36M |
| Total liabilities | 178.04M |
| Total equity | 441.32M |
| Cash & equivalents | 107.91M |
| Current assets | 259.35M |
| Current liabilities | 154.96M |
Cash Flow
| Line Item | 2026 Q1 |
|---|---|
| Operating cash flow | 31.21M |
| Investing cash flow | -52.1M |
| Financing cash flow | 37.78M |
| Change in cash | 16.9M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 4 — Ethos Technologies Inc. | View Filing | |
| edgar index | 4 — Ethos Technologies Inc. | View Filing | |
| edgar index | 4 — Ethos Technologies Inc. | View Filing | |
| edgar index | 4 — Ethos Technologies Inc. | View Filing | |
| edgar index | 4 — Ethos Technologies Inc. | View Filing | |
| edgar index | SCHEDULE 13G — Ethos Technologies Inc. | View Filing | |
| edgar index | SCHEDULE 13G — Ethos Technologies Inc. | View Filing | |
| edgar index | SCHEDULE 13G — Ethos Technologies Inc. | View Filing | |
| edgar index | 144 — Ethos Technologies Inc. | View Filing | |
| edgar index | 144 — Ethos Technologies Inc. | View Filing | |
| edgar index | 144 — Ethos Technologies Inc. | View Filing | |
| edgar index | 144 — Ethos Technologies Inc. | View Filing | |
| edgar index | 144 — Ethos Technologies Inc. | View Filing | |
| edgar index | 144 — Ethos Technologies Inc. | View Filing | |
| edgar index | SCHEDULE 13G — Ethos Technologies Inc. | View Filing | |
| edgar index | SCHEDULE 13G — Ethos Technologies Inc. | View Filing | |
| form 4 | Form 4 — GV 2021 GP, L.L.C. | View Filing | |
| form 4 | Form 4 — GV 2019 GP, L.L.C. | View Filing | |
| form 4 | Form 4 — GV 2021 GP, L.P. | View Filing | |
| form 4 | Form 4 — GV 2021 GP, L.P. | View Filing | |
| form 4 | Form 4 — GV 2019 GP, L.P. | View Filing | |
| form 4 | Form 4 — GV 2019 GP, L.P. | View Filing | |
| form 4 | Form 4 — GV 2021 GP, L.P. | View Filing | |
| form 4 | Form 4 — GV 2021, L.P. | View Filing | |
| form 4 | Form 4 — GV 2021, L.P. | View Filing | |
| form 4 | Form 4 — GV 2019 GP, L.P. | View Filing | |
| form 4 | Form 4 — GV 2021, L.P. | View Filing | |
| form 4 | Form 4 — GV 2019, L.P. | View Filing | |
| form 4 | Form 4 — GV 2019, L.P. | View Filing | |
| form 4 | Form 4 — Alphabet Inc. | View Filing | |
| form 4 | Form 4 — Alphabet Inc. | View Filing | |
| form 4 | Form 4 — GV 2021 GP, L.L.C. | View Filing | |
| form 4 | Form 4 — GV 2021 GP, L.L.C. | View Filing | |
| form 4 | Form 4 — GV 2019, L.P. | View Filing | |
| form 4 | Form 4 — Alphabet Inc. | View Filing | |
| form 4 | Form 4 — GV 2019 GP, L.L.C. | View Filing | |
| form 4 | Form 4 — GV 2019 GP, L.L.C. | View Filing | |
| form 4 | Form 4 — Kucharski Brandt Walter | View Filing | |
| form 4 | Form 4 — Kucharski Brandt Walter | View Filing | |
| form 4 | Form 4 — Capozzi Christopher M. | View Filing | |
| form 4 | Form 4 — Capozzi Christopher M. | View Filing | |
| form 4 | Form 4 — Wang Lingke | View Filing | |
| form 4 | Form 4 — Wang Lingke | View Filing | |
| form 4 | Form 4 — Wang Lingke | View Filing | |
| form 4 | Form 4 — Wang Lingke | View Filing | |
| form 4 | Form 4 — Wang Lingke | View Filing | |
| form 4 | Form 4 — Wang Lingke | View Filing | |
| form 4 | Form 4 — Wang Lingke | View Filing | |
| form 4 | Form 4 — Wang Lingke | View Filing | |
| form 4 | Form 4 — Wang Lingke | View Filing | |
| form 4 | Form 4 — Wang Lingke | View Filing | |
| form 4 | Form 4 — Wang Lingke | View Filing | |
| form 4 | Form 4 — Wang Lingke | View Filing | |
| form 4 | Form 4 — Colis Peter George | View Filing | |
| form 4 | Form 4 — Colis Peter George | View Filing | |
| form 4 | Form 4 — Colis Peter George | View Filing | |
| form 4 | Form 4 — Colis Peter George | View Filing | |
| form 4 | Form 4 — Colis Peter George | View Filing | |
| form 4 | Form 4 — Colis Peter George | View Filing | |
| form 4 | Form 4 — GV 2021 GP, L.L.C. | View Filing | |
| form 4 | Form 4 — GV 2019, L.P. | View Filing | |
| form 4 | Form 4 — Alphabet Inc. | View Filing | |
| form 4 | Form 4 — GV 2021 GP, L.P. | View Filing | |
| form 4 | Form 4 — Alphabet Inc. | View Filing | |
| form 4 | Form 4 — GV 2021 GP, L.L.C. | View Filing | |
| form 4 | Form 4 — GV 2019 GP, L.P. | View Filing | |
| form 4 | Form 4 — GV 2019 GP, L.L.C. | View Filing | |
| form 4 | Form 4 — GV 2021, L.P. | View Filing | |
| form 4 | Form 4 — GV 2021, L.P. | View Filing | |
| form 4 | Form 4 — GV 2019, L.P. | View Filing | |
| form 4 | Form 4 — GV 2021 GP, L.P. | View Filing | |
| form 4 | Form 4 — GV 2019, L.P. | View Filing | |
| form 4 | Form 4 — GV 2019 GP, L.P. | View Filing | |
| form 4 | Form 4 — Alphabet Inc. | View Filing | |
| form 4 | Form 4 — GV 2019 GP, L.P. | View Filing |